C16, a novel advanced glycation endproduct breaker, restores cardiovascular dysfunction in experimental diabetic rats.
about
Beneficial effects of C36, a novel breaker of advanced glycation endproducts cross-links, on the cardiovascular system of diabetic rats.Advanced glycation end-products (AGEs) and heart failure: pathophysiology and clinical implications.Pharmacological control of receptor of advanced glycation end-products and its biological effects in psoriasis.The receptor for advanced glycation endproducts (RAGE) and cardiovascular disease.Molecular strategies to prevent, inhibit, and degrade advanced glycoxidation and advanced lipoxidation end products.Synthesis and cytotoxic activity of certain benzothiazole derivatives against human MCF-7 cancer cell line.
P2860
C16, a novel advanced glycation endproduct breaker, restores cardiovascular dysfunction in experimental diabetic rats.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
C16, a novel advanced glycatio ...... in experimental diabetic rats.
@en
C16, a novel advanced glycatio ...... in experimental diabetic rats.
@nl
type
label
C16, a novel advanced glycatio ...... in experimental diabetic rats.
@en
C16, a novel advanced glycatio ...... in experimental diabetic rats.
@nl
prefLabel
C16, a novel advanced glycatio ...... in experimental diabetic rats.
@en
C16, a novel advanced glycatio ...... in experimental diabetic rats.
@nl
P2093
P2860
P1476
C16, a novel advanced glycatio ...... in experimental diabetic rats.
@en
P2093
Gang Cheng
Hong-Ying Liu
Li-Li Wang
Wen-Sheng Qu
Ying-Lin Cao
P2860
P304
P356
10.1111/J.1745-7254.2005.00240.X
P577
2005-12-01T00:00:00Z
P5875
P6179
1040016179